Abcam
About Abcam
Abcam is a Cambridge-headquartered global supplier of protein research tools, antibodies and reagents for life science research.
Milestones
Milestones as listed on danaher.com, sec.gov, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Products & Services
Products and services as listed on danaher.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Primary and secondary antibodies
Abcam's principal catalogue line: validated antibodies for key targets in biological pathways used in research and drug discovery.
Source: danaher.comConjugated antibodies and conjugation kits
Antibodies supplied pre-labelled, plus kits for researchers to attach their own labels.
Source: danaher.comSingleplex immunoassays
Single-analyte immunoassay kits forming one of Abcam's principal catalogue product lines.
Source: danaher.comPeptides and proteins
Recombinant proteins and peptides offered alongside the antibody catalogue.
Source: danaher.comKnockout cell lines and lysates
Gene-knockout cell lines and cell lysates for target validation work.
Source: danaher.comCellular activity kits and pathway tools
Cellular activity kits plus biochemical and cell-signalling pathway tools.
Source: danaher.comFinancials & Irish Entities
Group figures for Danaher Corporation, the parent company. From the annual reports Danaher Corporation files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.
| Year to | Revenue | R&D | R&D % | Net income | Filing |
|---|---|---|---|---|---|
| Dec 2025 | $24.57bn | $1.60bn | 6.5% | $3.61bn | 10-K 2026 |
| Dec 2024 | $23.88bn | $1.58bn | 6.6% | $3.90bn | 10-K 2026 |
| Dec 2023 | $23.89bn | $1.50bn | 6.3% | $4.76bn | 10-K 2026 |
| Dec 2022 | $26.64bn | $1.53bn | 5.7% | $7.21bn | 10-K 2025 |
| Dec 2021 | $24.80bn | $1.50bn | 6.0% | $6.43bn | 10-K 2024 |
Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.
Companies registered in Ireland 3 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Leica Biosystems (Dublin) Limited LTD - Private Company Limited by Shares | 371453 | 2003 | Dec 2024 |
| Beckman Coulter Diagnostics Limited LTD - Private Company Limited by Shares | 485929 | 2010 | Dec 2025 |
| Beckman Coulter Ireland Inc. Unlimited Company ULC - Private Unlimited Company | 501471 | 2011 | Dec 2024 |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Danaher Corporation as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.